H&R GmbH & Co KgaA
XETRA:2HRA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (1.6), the stock would be worth €8.97 (95% upside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0.8 | €4.6 |
0%
|
| 3-Year Average | 1.6 | €8.97 |
+95%
|
| 5-Year Average | 1.7 | €9.59 |
+109%
|
| Industry Average | 6.9 | €38.86 |
+745%
|
| Country Average | 9 | €50.57 |
+999%
|
Forward EV/EBITDA
Today’s price vs future ebitda
| Today's Enterprise Value | EBITDA | Forward EV/EBITDA | ||
|---|---|---|---|---|
|
€80.3m
|
/ |
Jan 2026
€124.3m
|
= |
|
|
€80.3m
|
/ |
Dec 2026
€83.1m
|
= |
|
|
€80.3m
|
/ |
Dec 2027
€88.2m
|
= |
|
|
€80.3m
|
/ |
Dec 2028
€90.7m
|
= |
|
Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| DE |
|
H&R GmbH & Co KgaA
XETRA:2HRA
|
171.2m EUR | 0.8 | -4.4 | |
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
83.6B USD | 20.9 | 32.4 | |
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
12.7T JPY | 12.9 | 26.1 | |
| US |
|
Ecolab Inc
NYSE:ECL
|
76.6B USD | 21.4 | 36.7 | |
| JP |
Y
|
Yasuhara Chemical Co Ltd
TSE:4957
|
10.8T JPY | 5.8 | 10.5 | |
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
274.4B CNY | 18 | 20.8 | |
| CH |
|
Givaudan SA
SIX:GIVN
|
26B CHF | 17 | 24.3 | |
| DK |
|
Novozymes A/S
CSE:NZYM B
|
165.6B DKK | 28.9 | 54.8 | |
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.4T INR | 37.2 | 61.8 | |
| US |
|
PPG Industries Inc
NYSE:PPG
|
24.6B USD | 10.8 | 15.6 | |
| CH |
|
Sika AG
F:SIKA
|
19.9B EUR | 10.3 | 17.5 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 6.2 |
| Median | 9 |
| 70th Percentile | 13.6 |
| Max | 6 112.6 |
Other Multiples
H&R GmbH & Co KgaA
Glance View
H&R GmbH & Co. KGaA is a holding company, which engages in the manufacture of mineral oil specialties. The company is headquartered in Salzbergen, Niedersachsen and currently employs 1,585 full-time employees. The company operates through three segments: Chemical-Pharmaceutical Raw Materials Refining (ChemPharm Refining), Chemical-Pharmaceutical Raw Materials Sales (ChemPharm Sales) and Plastics. The ChemPharm Refining segment comprises two refineries in Germany, which produce plasticizers, paraffins, white oils and base oils; the ChemPharm Sales segment includes production and distribution sites worldwide and its main products are label-free plasticizers for the tire industry, as well as paraffins for various applications, and the Plastics segment produces precision plastic parts and molding tools to manufacture precision plastic parts.
